http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0193855-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-10 |
| filingDate | 1986-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1990-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1990-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0193855-B1 |
| titleOfInvention | Hydantoin derivatives, processes for preparing them and pharmaceutical compositions containing them |
| abstract | Disclosed herein are hydantoin derivatives having the general formula (I) <CHEM> wherein X represents a halogen atom, and Y represents an amino or nitro group, and pharmacologically acceptable salts thereof, their preparation process and pharmaceutical compositions containing them as effective components. The hydantoin derivatives and their salts are used for the preparation of a composition for treating and preventing chronic symptoms and complications accompanying diabetes. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11147799-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11285099-B2 |
| priorityDate | 1985-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.